The retinal microenvironment in diabetic retinopathy
糖尿病视网膜病变的视网膜微环境
基本信息
- 批准号:8316113
- 负责人:
- 金额:$ 36.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcidosisAcuteAdultAffectAgeAnimalsBlood VesselsBlood capillariesBlood flowCarbonic AcidClinicalComplications of Diabetes MellitusDiabetes MellitusDiabetic RetinopathyDiseaseDisease ProgressionDropoutEndothelial CellsEnvironmental Risk FactorEventExcisionExperimental Diabetes MellitusExtravasationFelis catusFunctional disorderHyperglycemiaHypoxiaLeadLettersLinkLong-Evans RatsMeasurementMeasuresMessenger RNAMetabolismMichiganMicrospheresMolecularNeonatalOxygenPathway interactionsPhasePlayProteinsRattusRegulationRelative (related person)RetinaRetinalRetinal DiseasesRodentRoleSignal TransductionStreptozocinTestingTimeTissuesTreatment ProtocolsTumor TissueVascular Endothelial Growth FactorsWorkangiogenesiscapillarycarbonate dehydratasediabeticinsightinsulin signalingrelating to nervous systemresponsetranscription factortype I and type II diabetes
项目摘要
DESCRIPTION (provided by applicant): Diabetic retinopathy is one of the most common causes of retinal disease in adults. Many molecular and histological changes have been demonstrated, and it is now recognized that neural as well as vascular problems exist. The most important contributor to vascular dysfunction is the elevation of vascular endothelial growth factor (VEGF), which causes vascular leakage and angiogenesis. Unfortunately, we still do not know what underlies the increase in VEGF. Hypoxia and acidosis are both known regulators of VEGF, but the magnitude and time course of changes in retinal oxygen and pH are not known in diabetes. More information about these parameters will allow a better understanding of disease progression, and ultimately may lead to an understanding of pathways that can be targeted before VEGF causes damage. We will make intraretinal recordings of PO2 and pH in rats with streptozotocin (STZ)-induced diabetes, and in rats with acidosis in the absence of diabetes. To place these changes in the context of other events, we will also measure important vascular parameters (blood flow, leakage, molecular signals). SPECIFIC AIM 1: Oxygen in diabetic retinopathy. Retinal tissue hypoxia has been implicated in the increased VEGF that is found in both the background and proliferative phases of retinopathy. There is considerable indirect support for the existence of hypoxia in diabetic retinopathy, but very limited direct evidence. We will characterize intraretinal oxygenation in rats with up to 1 year of diabetes. Our hypothesis is that inner retinal PO2 will decrease over this time. We will also investigate changes in the regulation of retinal oxygen in diabetics. Our hypothesis is that changes in regulation of PO2 will be a more sensitive indicator of changes in the microenvironment and occur earlier than changes in baseline PO2. We found increased PO2 in the retina in an earlier study at 12 weeks of diabetes. Our hypothesis is that this was due to increased blood flow, which we will now investigate. SPECIFIC AIM 2: Acidosis in diabetic retinopathy. VEGF is regulated by acidosis in some tissues but the role of pH in controlling VEGF in the adult retina is unknown. We will characterize retinal pH in rats with up to 1 year of diabetes. Our hypothesis is that the inner retina will be more acidic than normal for at least a few months. We also hypothesize that molecular mechanisms come into play to reduce acidosis, such as increased carbonic anhydrase and acid removal mechanisms. These will be evaluated with mRNA and protein measurements. SPECIFIC AIM 3: Is retinal acidosis sufficient to upregulate VEGF? Finding that the diabetic retina is acidotic will open the possibility that it is one of the factors that regulates VEGF, but will not tell us whether it is important. Consequently, we will produce acidosis in the absence of diabetes, via carbonic anhydrase inhibition. We will first establish a treatment protocol that yields intraretinal pH values similar to diabetes, and then evaluate changes in VEGF and leakage. Our hypothesis is that acidosis alone will be sufficient to increase VEGF, produce molecular changes that underlie leakage, and cause leakage itself.
描述(由申请人提供):糖尿病视网膜病变是成人视网膜疾病的最常见原因之一。许多分子和组织学变化已得到证实,现在人们认识到存在神经和血管问题。血管功能障碍的最重要因素是血管内皮生长因子(VEGF)的升高,这会导致血管渗漏和血管生成。不幸的是,我们仍然不知道 VEGF 增加的原因是什么。缺氧和酸中毒都是已知的 VEGF 调节因子,但糖尿病中视网膜氧和 pH 值变化的幅度和时间过程尚不清楚。有关这些参数的更多信息将有助于更好地了解疾病进展,并最终可能导致了解 VEGF 造成损害之前可靶向的途径。我们将在链脲佐菌素 (STZ) 诱导的糖尿病大鼠和无糖尿病的酸中毒大鼠中进行 PO2 和 pH 的视网膜内记录。为了将这些变化置于其他事件的背景下,我们还将测量重要的血管参数(血流量、渗漏、分子信号)。具体目标 1:糖尿病视网膜病变中的氧气。视网膜组织缺氧与 VEGF 增加有关,这种增加出现在视网膜病变的背景期和增殖期。有相当多的间接支持糖尿病视网膜病变中存在缺氧,但直接证据非常有限。我们将描述患有糖尿病长达 1 年的大鼠的视网膜内氧合特征。我们的假设是,视网膜内 PO2 在此期间会下降。我们还将研究糖尿病患者视网膜氧调节的变化。我们的假设是,PO2 调节的变化将是微环境变化的更敏感指标,并且比基线 PO2 的变化更早发生。在一项早期研究中,我们发现糖尿病 12 周时视网膜中的 PO2 增加。我们的假设是,这是由于血流量增加所致,我们现在将对此进行研究。具体目标 2:糖尿病视网膜病变中的酸中毒。 VEGF 在某些组织中受到酸中毒的调节,但 pH 在控制成人视网膜中 VEGF 中的作用尚不清楚。我们将描述患有糖尿病长达 1 年的大鼠的视网膜 pH 值。我们的假设是,内部视网膜至少在几个月内会比正常情况更酸性。我们还假设分子机制在减少酸中毒方面发挥作用,例如增加碳酸酐酶和除酸机制。这些将通过 mRNA 和蛋白质测量进行评估。具体目标 3:视网膜酸中毒是否足以上调 VEGF?发现糖尿病视网膜酸中毒将开启它是调节 VEGF 的因素之一的可能性,但不会告诉我们它是否重要。因此,在没有糖尿病的情况下,我们会通过碳酸酐酶抑制产生酸中毒。我们将首先建立一个治疗方案,产生与糖尿病相似的视网膜内 pH 值,然后评估 VEGF 和渗漏的变化。我们的假设是,仅酸中毒就足以增加 VEGF,产生导致渗漏的分子变化,并导致渗漏本身。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT A. LINSENMEIER其他文献
ROBERT A. LINSENMEIER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT A. LINSENMEIER', 18)}}的其他基金
Spatially resolved measurements of retinal metabolism
视网膜代谢的空间分辨测量
- 批准号:
10153785 - 财政年份:2019
- 资助金额:
$ 36.75万 - 项目类别:
Spatially resolved measurements of retinal metabolism
视网膜代谢的空间分辨测量
- 批准号:
9906901 - 财政年份:2019
- 资助金额:
$ 36.75万 - 项目类别:
A clinically applicable model of retinal oxygen metabolism
临床适用的视网膜氧代谢模型
- 批准号:
9227475 - 财政年份:2017
- 资助金额:
$ 36.75万 - 项目类别:
The retinal microenvironment in diabetic retinopathy
糖尿病视网膜病变的视网膜微环境
- 批准号:
8723217 - 财政年份:2011
- 资助金额:
$ 36.75万 - 项目类别:
The retinal microenvironment in diabetic retinopathy
糖尿病视网膜病变的视网膜微环境
- 批准号:
8187702 - 财政年份:2011
- 资助金额:
$ 36.75万 - 项目类别:
The retinal microenvironment in diabetic retinopathy
糖尿病视网膜病变的视网膜微环境
- 批准号:
8531256 - 财政年份:2011
- 资助金额:
$ 36.75万 - 项目类别:
The retinal microenvironment in diabetic retinopathy
糖尿病视网膜病变的视网膜微环境
- 批准号:
8916116 - 财政年份:2011
- 资助金额:
$ 36.75万 - 项目类别:
Third Biomedical Engineering Education Summit Meeting
第三届生物医学工程教育高峰会议
- 批准号:
7484902 - 财政年份:2008
- 资助金额:
$ 36.75万 - 项目类别:
相似海外基金
Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
- 批准号:
2885806 - 财政年份:2023
- 资助金额:
$ 36.75万 - 项目类别:
Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
- 批准号:
10772386 - 财政年份:2023
- 资助金额:
$ 36.75万 - 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
474619 - 财政年份:2022
- 资助金额:
$ 36.75万 - 项目类别:
Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
- 批准号:
485965 - 财政年份:2022
- 资助金额:
$ 36.75万 - 项目类别:
Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
466358 - 财政年份:2022
- 资助金额:
$ 36.75万 - 项目类别:
Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
- 批准号:
402040 - 财政年份:2019
- 资助金额:
$ 36.75万 - 项目类别:
Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
- 批准号:
18K16103 - 财政年份:2018
- 资助金额:
$ 36.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
- 批准号:
377313 - 财政年份:2017
- 资助金额:
$ 36.75万 - 项目类别:
Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
- 批准号:
9315111 - 财政年份:2016
- 资助金额:
$ 36.75万 - 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
- 批准号:
8734273 - 财政年份:2013
- 资助金额:
$ 36.75万 - 项目类别:














{{item.name}}会员




